Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response.

Cancers (Basel) · 2021 · PMC7913874 · PMID 33557101

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

A post-hoc analysis of the data obtained from this clinical trial showed a favorable trend for patients with p53 and EGFR mutations [ 146 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.